Cargando…
Efficacy of Second-Line Treatments in Chronic Urticaria Refractory to Standard Dose Antihistamines
PURPOSE: The prevalence of chronic urticaria (CU) is increasing worldwide, and it imposes a major burden on patients. Few studies have evaluated the efficacy of second-line treatments of CU, particularly for patients being considered for costly third-line treatments such as omalizumab. We compared t...
Autores principales: | Kim, Mi-Ae, Choi, Jeong-Hee, Shin, Yoo-Seob, Park, Hae-Sim, Ye, Young-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359646/ https://www.ncbi.nlm.nih.gov/pubmed/37153977 http://dx.doi.org/10.4168/aair.2023.15.4.496 |
Ejemplares similares
-
Increased platelet activating factor levels in chronic spontaneous urticaria predicts refractoriness to antihistamine treatment: an observational study
por: Ulambayar, Bastsetseg, et al.
Publicado: (2019) -
Effects of Omalizumab Treatment in Patients With Refractory Chronic Urticaria
por: Nam, Young-Hee, et al.
Publicado: (2012) -
Pathobiology of Second-Generation Antihistamines Related to Sleep in Urticaria Patients
por: Mann, Caroline, et al.
Publicado: (2022) -
Hyperresponsiveness to antihistamines in spontaneous urticaria and heat urticaria
por: Durda, J., et al.
Publicado: (2017) -
Selecting optimal second-generation antihistamines for allergic rhinitis and urticaria in Asia
por: Recto, Marysia Tiongco, et al.
Publicado: (2017)